EDGEMOND JAMES (CFO) recently executed a sell of $94K in UNITED THERAPEUTICS CORP shares on April 9, 2026. Overall insider sentiment is bearish (99% sales).
UNITED THERAPEUTICS CORP (UTHR) has recorded 11 386 insider operations, including 43 open-market purchases ($15.1M), 5 219 sales ($2.0B) and 6 124 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (99% sales).
Among the most active insiders are ROTHBLATT MARTINE A (CEO), LILLY ELI & CO (CEO) & Ferrari John Maxim (CFO), with respectively 5625, 55, 301 transactions.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Advanced analytics coming soon
Price impact analysis, win rates, and predictive signals are being developed.